A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
This primarily occurs in the body in cases of urothelial carcinoma, a common form of bladder cancer. In pre-clinical trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback